Specialised international organisations already carried out substantial work to combat counterfeiting, with greater emphasis on the protection of intellectual property rights. However, there is a general recognition that, along with the violation of intellectual property rights, counterfeiting of pharmaceutical products and medical devices puts public health and the health of individuals at risk and therefore needs to be addressed as a matter of urgency.